Cantor Fitzgerald, L. P. »

Travere Therapeutics shares owned by Cantor Fitzgerald, L. P.

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Cantor Fitzgerald, L. P. from 13F filings

Historical chart of Cantor Fitzgerald, L. P. investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Cantor Fitzgerald, L. P. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Cantor Fitzgerald, L. P.

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.2M 50k 23.90
2025-06-30 $1.1M 75k 14.80
2025-03-31 $448k 25k 17.92
2024-09-30 $500k 36k 13.99

More positions owned by Cantor Fitzgerald, L. P.

Strategy Cl A (MSTR)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Advanced Micro Devices (AMD)
Tesla Motors (TSLA)
Robinhood Mkts Com Cl A (HOOD)
Super Micro Computer Inc Com Usd0.001 (SMCI)
UnitedHealth (UNH)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Rocket Lab Corp (RKLB)
Fidelity Wise Origin Bitcoin SHS (FBTC)
Oracle Corporation (ORCL)
Oklo Com Cl A (OKLO)
Broadcom (AVGO)
Rigetti Computing Common Stock (RGTI)

View all positions for Cantor Fitzgerald, L. P.

Top funds holding Travere Therapeutics

Henderson Group
BlackRock
Armistice Capital
Vanguard Group
Macquarie Group
Perceptive Advisors
Adage Capital Partners GP
State Street Corporation
FMR
Rock Springs Capital Management
Emerald Advisers
Geode Capital Management
Renaissance Technologies
Stephens Investment Management Group
Deutsche Bank Aktiengesellschaft

View all funds holding Travere Therapeutics